Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 22,614 |
|
|||||
| News | - | ||||||
| Day High | 1.3295 | Low High |
|||||
| Day Low | 1.26 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Imunon Inc | IMNN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.31 | 12:13:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.30 | 1.26 | 1.3295 | 1.31 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 70 | 22,614 | US$ 1.31 | US$ 29,585 | - | 0.48 - 2.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:14:01 | 5 | US$ 1.2999 | USD |
Imunon Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 12.31M | 9.40M | - | 0 | -19.52M | -2.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Imunon News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMNN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.32 | 1.48 | 1.26 | 1.38 | 47,815 | -0.01 | -0.76% |
| 1 Month | 1.78 | 1.79 | 1.04 | 1.39 | 106,289 | -0.47 | -26.40% |
| 3 Months | 0.55 | 2.00 | 0.48 | 1.23 | 232,784 | 0.76 | 138.18% |
| 6 Months | 0.9814 | 2.00 | 0.48 | 1.13 | 135,795 | 0.3286 | 33.48% |
| 1 Year | 1.31 | 2.00 | 0.48 | 1.14 | 80,165 | 0.00 | 0.00% |
| 3 Years | 1.96 | 2.00 | 0.48 | 1.24 | 71,086 | -0.65 | -33.16% |
| 5 Years | 1.96 | 2.00 | 0.48 | 1.24 | 71,086 | -0.65 | -33.16% |
Imunon Description
| Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. |
